Labryte

Labryte will be at the Executive War College this year.

We work closely with companies developing products for clinical laboratories (assays, platforms, software, and services) and help bridge the gap between product development and real world clinical adoption.
That gap is where most products fail.

Regulatory constraints, validation requirements, workflow friction, and reimbursement challenges are often underestimated until it’s too late.

Our founder, Amanda Natalizio, PhD, will be onsite meeting with organizations that want to pressure test their products against actual lab operations and compliance requirements.

This also marks our transition from Helix Molecular Solutions to Labryte, reflecting a more focused approach to helping companies successfully enter and scale in the clinical lab market.

If you’re attending EWC and want honest feedback on how your product will perform in a clinical setting, connect with us.

We’re evolving — Helix Molecular Solutions is now Labryte.

Over the past several years, Helix Molecular Solutions has grown far beyond its original scope. Our work now spans lab strategy, regulatory and compliance, validation, operations, and innovation across the clinical laboratory space.

As part of that growth, we’re rebranding to Labryte — a name that better reflects who we are today and where we’re going.

What’s not changing:
• Our team
• Our expertise
• Our commitment to scientific rigor, compliance, and quality

What is changing:
• Our name
• Our brand identity
• A clearer focus on building, supporting, and scaling high-quality laboratories

You may see both names referenced during the transition, but Labryte is the future.

Thank you to our clients, partners, and collaborators who’ve been part of this journey. We’re just getting started.

—
Labryte
(formerly Helix Molecular Solutions)

In 2023, staffing challenges are expected to be more complex than ever before.

2023 Clinical Lab Staffing Challenges: What You Need to Know Clinical laboratory staffing is a critical component of healthcare systems, playing an increasing role in healthcare delivery. In 2023, staffing challenges are expected to be more complex than ever before. Healthcare org...

An enzyme that is capable of effectively separating DNA strands for PCR purposes may end of use of thermocyclers for PCR.

The End of Thermocycler PCR In order to identify bacteria, viruses, and genetic mutations, the polymerase chain reaction (PCR) technique is frequently employed, which involves the amplification of nucleic acids through thermal cycling. However, a c...

On Monday, President Joe Biden revealed to Congress that he would be terminating the two national emergencies connected to COVID-19 on May 11. This comes after almost three years since the two were initially declared, as much of the world has moved back to a more typical state.

Biden Announces May 11th Date for Termination of COVID Emergency On Monday, President Joe Biden revealed to Congress that he would be terminating the two national emergencies connected to COVID-19 on May 11. This comes after almost three years since the two were initially declared, as...